

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | NF-κB ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ammonium pyrrolidine-1-carbodithioate | ✔ | 98% | |||||||||||||||||
| QNZ |
++++
NF-κB, IC50: 11 nM |
99%+ | |||||||||||||||||
| Sodium 4-Aminosalicylate Dihydrate | ✔ | 98% | |||||||||||||||||
| Sodium Salicylate | ✔ | 95% | |||||||||||||||||
| Parthenolide | ✔ | p53 | 97% HPLC | ||||||||||||||||
| JSH-23 |
+
NF-κB, IC50: 7.1 μM |
98% | |||||||||||||||||
| Phenethyl caffeate | ✔ | 98% | |||||||||||||||||
| Andrographolide | ✔ | 98+% | |||||||||||||||||
| Curcumin | ✔ | Nrf2,HDAC | 98% | ||||||||||||||||
| SC75741 |
+++
NF-κB, EC50: 200 nM |
99%+ | |||||||||||||||||
| CBL0137 HCl |
++
NF-κB, EC50: 0.47 μM |
p53 | 99%+ | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Nuclear Factor-kappa B (NF-κB) is a transcription factor family that regulates a large number of genes that are involved in important physiological processes, including survival, inflammation, and immune responses[3]. SC75741 is a potent inhibitor of NF-κB with an EC50 of 200 nM[2]. SC75741 also acts as a broad and efficient blocker of IV replication in non-toxic concentrations. The underlying molecular mechanism of SC75741 action involves impaired DNA binding of the NF-κB subunit p65, resulting in reduced expression of cytokines, chemokines, and pro-apoptotic factors, subsequent inhibition of caspase activation and block of caspase-mediated nuclear export of viralribonucleoproteins. SC75741 reduces viral replication and H5N1-induced IL-6 and IP-10 expression in the lung of infected mice. Besides its virustatic effect the drug suppresses virus-induced overproduction of cytokines and chemokines, suggesting that it might prevent hypercytokinemia that is discussed to be an important pathogenicity determinant of highly pathogenic IV. Importantly the drug exhibits a high barrier for development of resistant virus variants. Thus, SC75741-derived drugs may serve as broadly non-toxic anti-influenza agents[1]. |
| Concentration | Treated Time | Description | References | |
| HEK293WT cells | 5 µM | 6-12 hours | SC75741 enhanced autophagy activity | Front Pharmacol. 2021 Oct 29;12:741219 |
| LLC-PK cells | 20 µM | 24 hours | SC75741 inhibited PDCoV infection | Int J Mol Sci. 2022 Mar 18;23(6):3280 |
| SH-SY5YGT25 cells | 5 µM | 24 hours | SC75741 promoted TDP25 degradation | Front Pharmacol. 2021 Oct 29;12:741219 |
| H4GT25 cells | 5 µM | 24 hours | SC75741 significantly reduced TDP25 protein levels | Front Pharmacol. 2021 Oct 29;12:741219 |
| OCCM-30 cells | 5 µM | 2 hours | Inhibited the NF-κB pathway, reduced NLRP3 expression and pyroptosis in P. gingivalis-infected OCCM-30 cells | Heliyon. 2024 May 7;10(9):e30814 |
| Duck primary monocytes/macrophages | 1 µMol/mL | 24 hours | Evaluate the antiviral activity of SC75741 in duck monocytes/macrophages. Results showed that SC75741 significantly inhibited DPV replication. | Poult Sci. 2021 May;100(5):101085 |
| Duck primary astrocytes | 5 µMol/mL | 24 hours | Evaluate the antiviral activity of SC75741 in duck astrocytes. Results showed that SC75741 significantly inhibited VSV-GFP and DTMUV replication but had no effect on DPV. | Poult Sci. 2021 May;100(5):101085 |
| Duck primary neurons | 5 µMol/mL | 24 hours | Evaluate the antiviral activity of SC75741 in duck neurons. Results showed that SC75741 significantly inhibited VSV-GFP and DTMUV replication. | Poult Sci. 2021 May;100(5):101085 |
| T24 cells | 5 µM | 24 hours | Inhibition of NF-κB signaling pathway, reducing clonogenic survival and invasion capability of bladder cancer cells. | J Clin Med. 2019 Nov 13;8(11):1954 |
| MB49 cells | 5 µM | 24 hours | Inhibition of NF-κB signaling pathway, reducing clonogenic survival and invasion capability of bladder cancer cells. | J Clin Med. 2019 Nov 13;8(11):1954 |
| Duck embryo fibroblast cells (DEF) | 0.2–50 µMol/mL | 24, 48, or 72 hours | Evaluate the antiviral activity of SC75741 against VSV-GFP, DTMUV, and DPV-GFP. Results showed that SC75741 significantly inhibited viral replication in a dose-dependent manner. | Poult Sci. 2021 May;100(5):101085 |
| SW982 cells | 2 µM | 48 hours | Inhibited the expression of NF-κB and α-SMA, reduced levels of inflammatory markers TNF-α and IL-6 | Int J Mol Sci. 2021 Oct 14;22(20):11082 |
| Human nucleus pulposus cells | 5 µM | 6 and 12 hours | To investigate the inhibitory effect of SC75741 on the NF-κB signaling pathway, results showed that SC75741 reversed rhS100A9-induced NP cell apoptosis, matrix degradation, and inflammatory response. | J Cell Mol Med. 2021 May;25(10):4709-4720 |
| RAW264.7 cells | 2 µM | Overnight | Reduced the population of TRAP+ multinucleated cells and downregulated MMP9, RANKL, TRAP, and OPG proteins | Int J Mol Sci. 2021 Oct 14;22(20):11082 |
| Administration | Dosage | Frequency | Description | References | ||
| Wistar rats | Papain-induced osteoarthritis model | Oral | 15 mg/kg | Three times a week for 12 weeks | Ameliorated articular cartilage destruction, reduced OARSI scores, suppressed inflammatory markers NF-κB, TNF-α, IL-6, and miR-21, and promoted chondrogenesis inducers GDF-5, SOX5, TGF-β1, BMPR2, and COL4A1 | Int J Mol Sci. 2021 Oct 14;22(20):11082 |
| Nude mice (BALB/c-nu) | U251 cell xenograft tumor model | Intraperitoneal injection | 5 mg/kg | Once daily for 3 weeks | Inhibit NF-κB activity and reverse RIP2 overexpression-induced TMZ resistance | CNS Neurosci Ther. 2022 Dec;28(12):2319-2330. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.77mL 0.35mL 0.18mL |
8.84mL 1.77mL 0.88mL |
17.68mL 3.54mL 1.77mL |
|
| CAS号 | 913822-46-5 |
| 分子式 | C29H23N7O2S2 |
| 分子量 | 565.67 |
| SMILES Code | O=C(C1=CSC(C2CCN(C3=C4C(C=CS4)=NC=N3)CC2)=N1)NC5=NC6=CC=C(C(C7=CC=CC=C7)=O)C=C6N5 |
| MDL No. | MFCD18206785 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | QNZVBFMXWNWVKG-UHFFFAOYSA-N |
| Pubchem ID | 23661638 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 85 mg/mL(150.26 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1